(Press-News.org) Philadelphia, November 16, 2023 – Immunotherapies that target the CD20 antigen have revolutionized how patients with a variety of blood cancers and hematologic disorders have been treated. However, many patients develop resistance to these treatments due to a loss of the antigen that’s being targeted. Now, a new study from researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (Penn) has found that gene splicing occurring within these cells can cause significant changes in CD20 protein levels that render the therapies ineffective.
The findings, published today by the journal Blood, also demonstrate that patients with very low levels of CD20 may still be responsive to CAR-T therapy, something that was previously thought not possible. These findings may lead to more appropriate choices for therapy that maximize benefits to patients affected by a variety of blood cancers.
CD20 is a cell-surface protein involved in the fine-tuning of B cell responses to foreign agents like viruses. It is expressed exclusively on the surface of normal and malignant B cells and is not expressed by other cell types in the body. This makes CD20 an attractive target for monoclonal antibody therapies which have been used to treat a variety of B-cell lymphomas, including follicular lymphoma, Burkitt lymphoma, diffuse large B cell lymphomas and high-grade B-cell lymphomas.
Despite anti-CD20 therapies revolutionizing the way these conditions are treated, some patients with these conditions do not respond to antibodies targeting CD20, while others initially respond before eventually developing resistance. Prior research had shown that a loss of CD20 reduced the effectiveness of these immunotherapies, since it would remove their intended target. However, the mechanism by which CD20 levels can be reduced were poorly understood. Researchers at CHOP suspected that CD20 messenger RNA was not being properly translated into the CD20 protein expressed on the surfaces of cells.
“It does not matter how much mRNA is being made, it’s how effectively it is translated that matters,” said senior study author Andrei Thomas-Tikhonenko, PhD, chief of the Division of Cancer Pathobiology and a professor with the Department of Pathology and Laboratory Medicine at CHOP and Penn. “In this study, we found that certain isoforms of the mRNA responsible for producing CD20 were impacted by splicing in a way that the proteins were not being made at the levels necessary for these immunotherapies to do their job.”
In the study, researchers focused on the MS4A1 gene, which encodes for CD20. The gene undergoes splicing, or stitching together of its building blocks called exons, to produce several mRNA isoforms, which may encode the identical amino acid sequence, but differ in the efficiency with which the protein is made. The researchers identified four variants in total among normal and malignant cells. Of the four variants, V1 and V3 were by far the most abundant, yet only V3 is efficiently translated into CD20. In contrast, variant V1 had trouble recruiting ribosomes responsible for making proteins, making it difficult for monoclonal antibodies to target affected cells.
Surprisingly, CHOP researchers and their Penn collaborators, including Drs. Steven Schuster and Marco Ruella, also found that CAR T-cells were still able to effectively kill both V3- and V1-expressing cells. CAR T-cell therapy modifies patient’s own immune cells to kill cancer cells. Historically, CAR T-cell therapy presented challenges and was thought not to be effective in these malignancies, but the study showed that it was more effective in targeting both variants compared with the monoclonal antibody mosunetuzumab, which was only effective against V3-expressing cells.
“If a patient has relapsed because CD20 levels are downregulated, CAR T-cell therapy may still be an option, as it requires a lower threshold of the protein in order to be effective,” said first study author Zhiwei Ang, PhD, Research Associate Scientist in the Thomas-Tikhonenko lab. “These findings may help clinical staff offer more precise options when treating these hematologic malignancies.”
This study was supported by grants from the National Institutes of Health grants U01 CA232563, U01 CA232563-S3, U01 CA232486, U01 CA243072, and T32 CA009615, United States Department of Defense grant CA180683P1, The V Foundation for Cancer Research grant T2018-014, The Emerson Collective grant 886246066, the Leukemia & Lymphoma Society, the Joshua Kahan Endowed Chair in Pediatric Leukemia Research and the Mildred L. Roeckle Endowed Chair in Pathology at CHOP.
Ang et al, “Alternative splicing of its 5’-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies.” Blood. 142 (2023) pp. 1724-1739. DOI: 10.1182/blood.2023020400.
About Children’s Hospital of Philadelphia: A non-profit, charitable organization, Children’s Hospital of Philadelphia was founded in 1855 as the nation’s first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, the 595-bed hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. The institution has a well-established history of providing advanced pediatric care close to home through its CHOP Care Network, which includes more than 50 primary care practices, specialty care and surgical centers, urgent care centers, and community hospital alliances throughout Pennsylvania and New Jersey, as well as an inpatient hospital campus with a dedicated pediatric emergency department in King of Prussia. In addition, its unique family-centered care and public service programs have brought Children’s Hospital of Philadelphia recognition as a leading advocate for children and adolescents. For more information, visit https://www.chop.edu.
Gene splicing reduces effectiveness of CD20-targeting monoclonal antibodies designed to treat variety of blood cancers and disorders
Researchers found CAR T-cell therapy may serve as effective alternative for patients with these disorders
ELSE PRESS RELEASES FROM THIS DATE:
IVI signs MOU with University of Cambridge, University of Hong Kong, and the Hong Kong Jockey Club to establish the Hong Kong Jockey Club Global Health Institute
November 16, 2023, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, signed an MOU yesterday with University of Cambridge (UCAM), University of Hong Kong (HKU), and the Hong Kong Jockey Club (HKJC) to promote vaccine research and global health initiatives, including the establishment of the Hong Kong Jockey Club Global Health Institute (HKJCGHI). HKJC will support the HKJCGHI through one of their largest donations in history, ...
Incidence of recurrence and time to recurrence in Stage I to III colorectal cancer
About The Study: In this study of 34,000 patients with colorectal cancer (CRC) who underwent surgery from 2004 to 2019, the risk of recurrence decreased over time, and higher disease stage was associated with shorter times from surgery to recurrence. Screening-detected CRC was associated with a lower risk of recurrence. Because the risk of recurrence was so low in selected patient groups, future research is warranted to explore risk-stratified surveillance protocols in patients with CRC. Authors: Claus Lindbjerg Andersen, Ph.D., of Aarhus University Hospital in Aarhus, Denmark, ...
New efforts to improve cardiovascular, stroke care in rural areas
DALLAS, November 16, 2023 — Cardiovascular mortality is on the rise in rural areas of the United States, where more than 60 million Americans live, according to an American Heart Association presidential advisory. Understanding and addressing the unique health needs of people in rural America is critical to the Association’s pursuit of a world of longer, healthier lives. Today — on National Rural Health Day — the Association, the world’s leading nonprofit organization focused on heart and brain health for all, announces two new collaborative efforts to help close the gap between ...
Make a list, check it twice with these heart-healthy holiday travel hacks
DALLAS, Nov. 16, 2023 — For people living with a health condition like heart disease or stroke, traveling away from home can pose some special challenges. The American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives for all, says with a little pre-travel prep, you can turn travel woes from “oh no” to “let’s go!” “As we look forward to the holidays, many people will be traveling to spend treasured time with family and friends, or maybe just to enjoy some ...
Two new clinical trials find first-ever safe and effective treatment to prevent multidrug-resistant TB in both children and adults: Results presented at the Union Conference in Paris
PARIS (16 November, 2023)—Two landmark clinical trials reported today at the Union meeting showed that an oral antibiotic taken for six months once-daily substantially reduced the risk of developing drug-resistant TB. The antibiotic levofloxacin safely reduced the risk of multidrug-resistant (MDR) tuberculosis (TB) disease in children by 56%, researchers from the Desmond Tutu TB Centre at Stellenbosch University announced at the Union Conference in Paris today. The Unitaid-funded trial also showed that levofloxacin given once ...
AI model can help predict survival outcomes for patients with cancer
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have developed an artificial intelligence (AI) model based on epigenetic factors that is able to predict patient outcomes successfully across multiple cancer types. The researchers found that by examining the gene expression patterns of epigenetic factors — factors that influence how genes are turned on or off — in tumors, they could categorize them into distinct groups to predict patient outcomes across various cancer types better than traditional measures like cancer grade and stage. These findings, described in Communications Biology, also lay the groundwork ...
Wearable devices detect circadian disturbances that predict frailty risk in older adults
Brigham researchers found an association between alterations in circadian rest-activity rhythms and risk of frailty incidence in older adults Wearable devices can be used to measure a variety of signs and signals related to our health. A new study by researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, suggests that such devices may also be able to help predict older adults at risk of health complications related to frailty. The team found an association between disturbances in daily patterns of rest and activity, or circadian ...
Inequality hotspot map shows where women in agriculture are hit the hardest by the climate crisis
Threats posed by the climate crisis disproportionally affect certain communities and social groups that are more exposed. People living in low- and middle-income (LMIC) countries are at heightened risk. Within these countries, women typically face higher climate risk than men. To show where women working in agri-food systems – systems that encompass production, but also post-harvest handling and distribution – are most threated by climate change, an international team of researchers has developed a hotspot map that identifies and ranks localities by threat level. “We show that significant ...
Reclaiming carbon fibers from discarded composite materials
Minimizing energy consumption is a fundamental element in our journey towards sustainable societies, and advanced materials play a key role in this regard. Carbon-fiber-reinforced plastics (CFRPs) and carbon-fiber-reinforced thermoplastics (CFRTPs) are two prominent examples of composite materials that can significantly improve energy efficiency in various fields of application. These composites are made of carbon fibers embedded in a polymer matrix, such as epoxy resin. Thanks to their low weight and remarkable mechanical strength, CFRPs and CFRTPs can greatly ...
Break free from dependence on Japan by developing core electric vehicle components
A research team led by Dr. Jae-woong Ko from the Department of Engineering Ceramics at the Korea Institute of Materials Science(KIMS) has succeeded in localizing silicon nitride bearing ball manufacturing technology for electric vehicle drive modules. KIMS is a government-funded research institute under the Ministry of Science and ICT. This achievement is significant because it overcomes the limitations of foreign dependence and opens up the possibility of domestic supply and demand. Silicon nitride bearing ...
LAST 30 PRESS RELEASES:
Tracing how the infant brain responds to touch with near-infrared spectroscopy
These are the world's most effective charities
When is an aurora not an aurora?
Advisory panel issues field-defining recommendations for US government investments in particle physics research
Doctors discover many patients at UNC’s Inflammatory Bowel Disease Clinic screen positive for malnutrition
BNL: Advisory panel issues field-defining recommendations for U.S. government investments in particle physics research
International collaboration uses faculty member’s research on ancient Roman migration, seeks to understand Balkan genomic history
USF Health Heart Institute doctors are upbeat about cardiac regeneration
AI-driven breakthroughs in cells study: SFU-UBC collaboration introduces "MCS-detect" for advancements in super-resolution microscopy
Advisory panel issues field-defining recommendations for investments in particle physics research
$3.8 million NIH grant to fund Southwest Center on Resilience for Climate Change and Health
What happens when the brain loses a hub?
Study reveals Zika’s shape-shifting machinery—and a possible vulnerability
RIT leading STEM co-mentoring network
Genetic mutations that promote reproduction tend to shorten human lifespan, study shows
CAMH develops potential new drug treatment for multiple sclerosis
Polyethylene waste could be a thing of the past
A dynamic picture of how we respond to high or low oxygen levels
University of Toronto researchers discover new lipid nanoparticle that shows muscle-specific mRNA delivery, reduces off-target effects.
Evolving insights in blood-based liquid biopsies for prostate cancer interrogation
Finding the most heat-resistant substances ever made
Time-tested magnesium oxide: Unveiling CO2 absorption dynamics
Engaging heterosexual men more effectively could slash HIV infections in Uganda
A fork in the rhod: Janelia researchers unveil comprehensive collection of rhodamine-based fluorescent dyes
The Gerontological Society of America congratulates new 2023 awardees
Texas A&M Institute part of national effort to harness nuclear laser fusion for limitless energy
How health system hesitancies contributed to COVID risks
Stand Up to Cancer names Julian Adams, Ph.D., President and CEO
Immersive VR goggles for mice unlock new potential for brain science
Racial and ethnic differences in hospice use among Medicaid-only and dual-eligible decedents[Press-News.org] Gene splicing reduces effectiveness of CD20-targeting monoclonal antibodies designed to treat variety of blood cancers and disorders
Researchers found CAR T-cell therapy may serve as effective alternative for patients with these disorders